Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000150

Director sold 1,666 shares at $23.39 ($38,968)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
SATO VICKI L Director 2023-12-15 Sale 10b5-1 −1,666 $23.39 $38,968 124,707 D: show line 1 in the form
Open-market sales · 1,666 sh · avg $23.39 · $38,968
Loading xslF345X05/wk-form4_1702945827.xml…